1. Prospective phase II study of neoadjuvant doxorubicin followed by cisplatin/docetaxel in locally advanced breast cancer

   • Taher A. Al-Tweigeri
   • Dahish S. Ajarim
   • Adnan A. Ezzat

   Original Paper 13 June 2009 Pages: 571 - 577

   

2. c-erbB-2 and the “triple-state” in early breast carcinomas

   • Efthimios Sivridis
   • Charilaos Stamos
   • Alexandra Giatromanolaki

   Original Paper 23 June 2009 Pages: 578 - 584

   

3. Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer

   • M. Degirmenci
   • B. Karaca
   • R. Uslu

   Original Paper 13 June 2009 Pages: 585 - 591

   

4. Treatment of prostate and breast tumors employing mono- and bi-specific antisense oligonucleotides targeting apoptosis inhibitory proteins clusterin and bcl-2

   • Marvin Rubenstein
   • Paulus Tsui
   • Patrick Guinan

   Original Paper 16 June 2009 Pages: 592 - 599

   

5. Low molecular weight fraction secreted by SKOV3 cells expands peripheral CD4+CD25+ regulatory T cells and enhances their suppressive capacity

   • Xiao Li
   • Xiaoyun Wan
   • Xing Xie

   Original Paper 17 June 2009 Pages: 600 - 606

   

6. Characteristics and quality of life analysis of caregivers of cancer patients

   • Serap Alptekin
   • Güzin Gönüllü
   • Füsun Yarış

   Original Paper 10 July 2009 Pages: 607 - 617

7. Bone marrow hyaluronan and reticulin in patients with malignant disorders

   • G. Sundström
   • M. Hultdin
   • I. M. S. Dahl

   Original Paper 23 June 2009 Pages: 618 - 623

   

8. Verification of a prolonged untreated natural history of breast cancer by the multigene assay

   • Tadeja Urbas
   • Neal Agee
   • Ian K. Komenaka

   Original Paper 23 June 2009 Pages: 624 - 627

   

9. Palliative radiotherapy for the skin metastasis of ovarian cancer: a case report and review of the literature

   • Senem Demirci
   • Fatma Yavas
   • Arif B. Aras

   Original Paper 18 June 2009 Pages: 628 - 631

   

10. Downregulation of ABI1 expression affects the progression and prognosis of human gastric carcinoma

    • Meihua Cui
    • Weidong Yu
    • Yulan Liu

    Original Paper 25 June 2009 Pages: 632 - 639

    

11. Incidence of FLT3 and nucleophosmin gene mutations in childhood acute myeloid leukemia: Serbian experience and the review of the literature

    • Nada Krstovski
    • Natasa Tosic
    • Sonja Pavlovic

    Original Paper 26 June 2009 Pages: 640 - 645

    

12. Multiple myeloma: management of adverse events

    • F. Gay
    • A. Palumbo

    Original Paper 07 July 2009 Pages: 646 - 653

13. MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell

    • Tan Hao-Xiang
    • Wang Qian
    • Zhang Long-juan

    Original Paper 02 July 2009 Pages: 654 - 660

    

14. Primary gastrointestinal non-Hodgkin’s lymphoma: clinicopathological and prognostic analysis

    • Tong Wang
    • Wei Gui
    • Quanliang Shen

    Original Paper 30 June 2009 Pages: 661 - 666

    

15. Jumping translocation in acute monocytic leukemia (M5b) with alternative breakpoint sites in the long arm of donor chromosome 3

    • Peter McGrattan
    • Amy Logan
    • Margaret Bowers

    Original Paper 22 July 2009 Pages: 667 - 672

    

16. The role of heterogeneous nuclear ribonucleoprotein K in the progression of chronic myeloid leukemia

    • Qingfeng Du
    • Li Wang
    • Xiaoli Liu

    Original Paper 04 August 2009 Pages: 673 - 679

    

17. The efficacy and safety of reduced-dose docetaxel, cisplatin, and 5-fluorouracil in the first-line treatment of advanced stage gastric adenocarcinoma

    • Nuriye Yıldırım Özdemir
    • Hüseyin Abalı
    • Nurullah Zengin

    Original Paper 25 July 2009 Pages: 680 - 684

    

18. Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance

    • Yuanyuan Zhang
    • Junming Guo
    • Hui Zhuo

    Original Paper 14 July 2009 Pages: 685 - 689

    

19. Intestinal permeability, vitamin A absorption, alpha-tocopherol, and neopterin in patients with rectal carcinoma treated with chemoradiation

    • Josef Dvořák
    • Bohuslav Melichar
    • Dagmar Solichová

    Original Paper 24 July 2009 Pages: 690 - 696

    

20. The protective effects of ambroxol on radiation lung injury and influence on production of transforming growth factor β₁ and tumor necrosis factor α

    • De-Hong Xia
    • Lei Xi
    • Min Dai

    Original Paper 28 July 2009 Pages: 697 - 701

21. High efficacy and low toxicity of APL induction with concurrent idarubicin/ATRA followed by a novel and simplified outpatient post-remission therapy using single doses of idarubicin and intermittent ATRA

    • M. Aljurf
    • F. Al Qurashi
    • N. Chaudhri

    Original Paper 08 August 2009 Pages: 702 - 707

    

22. Biological characteristics of a specific brain metastatic cell line derived from human lung adenocarcinoma

    • Ling Hu
    • Junqing Zhang
    • Helong Zhang

    Original Paper 08 August 2009 Pages: 708 - 714

    

23. Inhibition of the EGFR with nanoparticles encapsulating antisense oligonucleotides of the EGFR enhances radiosensitivity in SCCVII cells

    • Yehui ping
    • Zou Jian
    • Liu Shixi

    Original Paper 04 August 2009 Pages: 715 - 721

    

24. Role of low dose capecitabine combined to irinotecan in advanced and metastatic gastric cancer

    • Fadi S. Farhat
    • Joseph Kattan
    • Marwan G. Ghosn

    Original Paper 31 July 2009 Pages: 722 - 727

    

25. A pilot study of carboplatin and mitoxantrone in blast crisis of chronic myeloid leukemia

    • Janice P. Dutcher
    • Evelyn L. Morris
    • Peter H. Wiernik

    Original Paper 21 August 2009 Pages: 728 - 735

26. Tumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo

    • Yu-gang Wu
    • Guang-zhou Wu
    • De-Chun Li

    Original Paper 08 August 2009 Pages: 736 - 742

    

27. Expression of complement regulatory proteins: CD46, CD55, and CD59 and response to rituximab in patients with CD20(+) non-Hodgkin’s lymphoma

    • Justyna Dzietczenia
    • Tomasz Wróbel
    • Kazimierz Kuliczkowski

    Original Paper 07 August 2009 Pages: 743 - 746

    

28. Alternations of ER, PR, HER-2/neu, and P53 protein expression in ductal breast carcinomas and clinical implications

    • Caigang Liu
    • Hao Zhang
    • Ping Lu

    Original Paper 06 August 2009 Pages: 747 - 752

    

29. Gefitinib-induced interstitial lung disease-addition of intravenous cyclophosphamide to corticosteroids is a valuable treatment option: A case report

    • Yasushi Goto
    • Masayuki Hojo
    • Koichiro Kudo

    Original paper 04 August 2009 Pages: 753 - 755

    

30. Micrometastasis of papillary thyroid carcinoma in a human immunodeficiency virus-infected patient: a case report and discussion

    • Célia Lloret Linares
    • Didier Troisvallets
    • Laurence Leenhardt

    Original Paper 06 August 2009 Pages: 756 - 759

    

31. The finding of a reciprocal whole-arm translocation t(X;12)(p10;p10) in association with atypical chronic myeloid leukaemia

    • P. T. Elder
    • M. F. McMullin
    • P. McGrattan

    Original Paper 06 August 2009 Pages: 760 - 762

    

32. Interstitial lung disease in patients with small cell lung cancer

    • Kunihiko Miyazaki
    • Hiroaki Satoh
    • Nobuyuki Hizawa

    Original Paper 06 August 2009 Pages: 763 - 767

    

33. Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors

    • Onder Tonyali
    • Ugur Coskun
    • Suleyman Buyukberber

    Original Paper 07 August 2009 Pages: 768 - 773

    

34. Suppression of matrix metalloproteinase-9 expression by RNA interference inhibits SGC7901 gastric adenocarcinoma cell growth and invasion in vitro and in vivo

    • Fengjuan Zhao
    • Qingyu Zhang
    • Xiaomei Song

    Original Paper 13 August 2009 Pages: 774 - 784

    

35. Growth inhibition and cell-cycle arrest of human gastric cancer cells by Lycium barbarum polysaccharide

    • Ying Miao
    • Bingxiu Xiao
    • Junming Guo

    Original Paper 11 August 2009 Pages: 785 - 790

    

36. Aberrant methylation profile of 14-3-3 sigma and its reduced transcription/expression levels in Chinese sporadic female breast carcinogenesis

    • Jie Luo
    • Jing Feng
    • Wenbin Li

    Original Paper 14 August 2009 Pages: 791 - 797

    

37. Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphoma

    • Hui-Hui Ma
    • Li-Ting Qian
    • Ai-Dong Wu

    Original Paper 15 August 2009 Pages: 798 - 806

    

38. Management of venous thromboembolism in colorectal cancer patients treated with bevacizumab

    • Mitsukuni Suenaga
    • Nobuyuki Mizunuma
    • Kiyohiko Hatake

    Original Paper 21 August 2009 Pages: 807 - 814

    

39. Postmenopausal bleeding as first sign of an acute myelogenous leukaemia: A case report and review of the literature

    • M. Henes
    • A. Nauth
    • J. C. Henes

    Original Paper 10 September 2009 Pages: 815 - 819

    

40. Tumor burden status evaluated by computed tomography scan is of prognostic importance in patients with chronic lymphocytic leukemia

    • Stefan Norin
    • Eva Kimby
    • Jeanette Lundin

    Original Paper 25 August 2009 Pages: 820 - 825

    

41. Primary thyroid marginal zone B-cell lymphoma MALT-type in a patient with rheumatoid arthritis

    • Songul Serefhanoglu
    • Umit Tapan
    • Aysegul Uner

    Original Paper 25 August 2009 Pages: 826 - 832

    

42. Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-κB-mediated induction of XIAP, cIAP2, BCL-X_L and survivin

    • Majid Momeny
    • Majid Zakidizaji
    • Seyed H. Ghaffari

    Original Paper 10 September 2009 Pages: 833 - 842

    

43. Combination gene therapy with PTEN and EGFR siRNA suppresses U251 malignant glioma cell growth in vitro and in vivo

    • Lei Han
    • An-ling Zhang
    • Chun-sheng Kang

    Original Paper 29 August 2009 Pages: 843 - 852

    

44. Evaluation of PTEN and Mcl-1 expressions in NSCLC expressing wild-type or mutated EGFR

    • Zafer Cetin
    • Gulay Ozbilim
    • Sibel Berker Karauzum

    Original Paper 10 September 2009 Pages: 853 - 860

    

45. p53 codon 72 polymorphism and risk of cervical carcinoma in Moroccan women

    • M. Meftah El khair
    • M. M. Ennaji
    • M. El Mzibri

    Original paper 23 September 2009 Pages: 861 - 866

    

46. Prognostic significance of tissue factor pathway inhibitor-2 in pancreatic carcinoma and its effect on tumor invasion and metastasis

    • Zhigang Tang
    • Guangyong Geng
    • Jiansheng Li

    Original Paper 10 September 2009 Pages: 867 - 875

    

47. Two “childhood” malignancies in an elderly individual: a case report and discussion

    • Lohith S. Bachegowda
    • Gayathri Nagaraj
    • Michael Styler

    Original Paper 04 September 2009 Pages: 876 - 879

    

48. p120ctn isoform 1 expression significantly correlates with abnormal expression of E-cadherin and poor survival of lung cancer patients

    • Yuan Miao
    • Nan Liu
    • En-Hua Wang

    Original Paper 11 September 2009 Pages: 880 - 886

    

49. Anti-p53 antibodies in serum: relationship to tumor biology and prognosis of breast cancer patients

    • A. Kulić
    • M. Sirotković-Skerlev
    • D. Vrbanec

    Original Paper 11 September 2009 Pages: 887 - 893

    

50. Prediction and identification of tumor-specific noncoding RNAs from human UniGene

    • Xinting Sang
    • Haitao Zhao
    • Shouxian Zhong

    Original Paper 12 September 2009 Pages: 894 - 898